We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Acute Promyelocytic Leukemia Rapidly Diagnosed by Immunostaining

By LabMedica International staff writers
Posted on 24 Dec 2013
Print article
Image: Bone marrow smear from a patient with hypergranular acute promyelocytic leukemia (Photo courtesy of the Armed Forces Institute of Pathology).
Image: Bone marrow smear from a patient with hypergranular acute promyelocytic leukemia (Photo courtesy of the Armed Forces Institute of Pathology).
Antipromyelocytic leukemia (PML) immunofluorescence staining is a known diagnostic tool for rapid diagnosis of acute promyelocytic leukemia (APL).

Recently developed and commercially available, tetramethylrhodamine-5-isothiocyanate–labeled PG-M3 anti-PML antibody for APL diagnosis has been tested in a clinical setting.

A team of scientists at the University of Texas MD Anderson Cancer Center (Houston, TX, USA) used immunofluorescence staining with the tetramethylrhodamine-5-isothiocyanate–labeled PG-M3 antibody to detect PML-retinoic acid receptor alpha (RARA) in bone marrow aspirate and/or peripheral blood smears from 30 patients with acute leukemia between February 1, 2011, and March 31, 2012. The results were compared with those of concurrent testing with our in-house polyclonal anti-PML antibody and with established tests.

For immunofluorescence staining, they used the tetramethylrhodamine-5-isothiocyanate (TRITC)-conjugated anti-PML monoclonal antibody PG-M3 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). All APL cases showed a positive, fine and/or microgranular, immunofluorescence staining pattern, whereas non-APL cases showed a negative, chunky and/or macrogranular pattern. These results, which were available within two hours, were validated by testing with the polyclonal anti-PML antibody and with established cytogenetic and molecular testing methods.

The authors concluded that they had validated the utility of the TRITC–labeled anti-PML antibody PG-M3 for the diagnosis of APL. Their results indicate that immunofluorescence staining with this antibody is a rapid and reliable method for the diagnosis of APL. The study was published on in the journal Archives of Pathology & Laboratory Medicine.

Related Links:

The University of Texas MD Anderson Cancer Center
Santa Cruz Biotechnology  


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.